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Abstract
Background: The limited duration and compromised efficiency of oocyte-mediated reprogramming, which occurs
during the early hours following somatic cell nuclear transfer (SCNT), may significantly interfere with epigenetic
reprogramming, contributing to the high incidence of ill/fatal transcriptional phenotypes and physiological anomalies
occurring later during pre- and post-implantation events. A potent histone deacetylase inhibitor, trichostatin A (TSA),
was used to understand the effects of assisted epigenetic modifications on transcriptional profiles of SCNT blastocysts
and to identify specific or categories of genes affected.
Results: TSA improved the yield and quality of in vitro embryo development compared to control (CTR-NT).
Significance analysis of microarray results revealed that of 37,238 targeted gene transcripts represented on the
microarray slide, a relatively small number of genes were differentially expressed in CTR-NT (1592 = 4.3 %) and
TSA-NT (1907 = 5.1 %) compared to IVF embryos. For both SCNT groups, the majority of downregulated and
more than half of upregulated genes were common and as much as 15 % of all deregulated transcripts were
located on chromosome X. Correspondence analysis clustered CTR-NT and IVF transcriptomes close together
regardless of the embryo production method, whereas TSA changed SCNT transcriptome to a very clearly
separated cluster. Ontological classification of deregulated genes using IPA uncovered a variety of functional
categories similarly affected in both SCNT groups with a preponderance of genes required for biological
processes. Examination of genes involved in different canonical pathways revealed that the WNT and FGF
pathways were similarly affected in both SCNT groups. Although TSA markedly changed epigenetic reprogramming of
donor cells (DNA-methylation, H3K9 acetylation), reconstituted oocytes (5mC, 5hmC), and blastocysts (DNA-methylation,
H3K9 acetylation), these changes did not recapitulate parallel marked changes in chromatin remodeling, and nascent
mRNA and OCT4-EGFP expression of TSA-NT vs. CRT-NT embryos.
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Conclusions: The results obtained suggest that despite the extensive reprogramming of donor cells that occurred
by the blastocyst stage, SCNT-specific errors are of a non-random nature in bovine and are not responsive to
epigenetic modifications by TSA.
Keywords: Somatic cell nuclear transfer, Trichostatin A, Transcriptome, Bovine
Background
Early embryonic development in mammals begins in
transcriptional silence [1] with an oocyte-mediated tran-
scriptional reprogramming of parental gametes occurring
during an across-the-board process of “erase-and-rebuild”
[2]. In this process, the parental transcription programs are
erased long before (maternal) or soon after (paternal)
fertilization to generate a relatively naïve zygotic chromatin
upon which the transcription program of a new life cycle is
rebuilt de novo after activation of the zygotic genome [2, 3].
Any perturbation in this process will result in ill or fatal
transcriptional phenotypes of the resultant embryos [4].
The very few viable clones obtained at the end of a typical
cloning experiment underscore that substantial differences
exist between transcriptional reprogramming of somatic
cell nuclei and gametes [5].
Six microarray studies have been carried out to explore
the transcriptomic profiles of cloned (SCNT) vs. fertilized
(IVF) bovine blastocysts [4, 6–10] and all reported extensive
transcriptional reprogramming of the donor cells by the
blastocyst stage with few genes, even as low as twenty [8],
being deregulated in SCNT embryos. Conversely, nu-
merous studies have reported abnormal patterns of
DNA-methylation and histone acetylation/methylation
of bovine clones [11–14]. These studies concluded that
bovine SCNT embryos suffer from genome-wide hyper-
methylation, associated with elevated heterochromatic
histone methylation (H3K9me2) and H3K9 acetylation
in the trophectoderm layer. Therefore, a typical SCNT
embryo may be transcriptionally close to (euchromatin),
but epigenetically far from (heterochromatin), normal em-
bryos, demonstrating that epigenetic but not expression
barriers limit reprogramming efficiency [15]. Accordingly, it
would be interesting to determine how small transcriptional
aberrations translate into broad epigenetic anomalies or
vice versa.
Somatic cell chromatin is compact and static, due to
the tight association of chromatin with heterochromatin
binding proteins and of histones with chromatin. Proper
erasure of these epigenotype markers is essential for
chromatin remodeling and pluripotency, as restricting
the exchange of these chromatin factors makes the chro-
matin inaccessible to oocyte reprogramming factors [13].
The short duration and compromised efficiency of the
erasure process is considered to be the main cause of
the transcriptomic and epigenomic anomalies of cloned
embryos [16]. To circumvent this problem, assisted epigen-
etic modification of somatic cells, before and/or soon after
SCNT, with DNA-methyltransferase (DNMTi) and histone
deacetylase (HDACi) inhibitors has been recently used to
assist the endogenous epigenome-modifying machinery
and enhance the speed and extent of nuclear reprogram-
ming (for review see [17]). Among these, members of the
hydroxamic acid-containing class of HDACi such as
Trichostatin A (TSA) and Scriptaid are used more fre-
quently due to their potent effects on global acetylation.
Given the genome-wide effects of HDACi, increased
acetylation results in the increased chromatin relaxation at
locations that are associated with pluripotency, and this is
expected to provide a chromatin conformation more per-
missive to transcriptional activation [18].
Treatment with TSA improved the development of
SCNT bovine [17–19] and pig [20, 21] embryos to the
blastocyst stage. In mice, TSA improved both nuclear
remodeling [22] and development to term [23–25].
Treatment with TSA also induced a parallel increase in
histone acetylation, chromosome decondensation and
nuclear volume in SCNT mouse embryos similar to
that observed in ICSI-derived embryos [26]. Import-
antly, through analysis of chromatin remodeling and 5-
bromouridine 5′-triphosphate (BrUTP)-labeled RNA,
Bui et al. [26] and VanThuan et al. [27] demonstrated a
more effective formation of DNA replication complexes
in TSA and Scriptaid treated embryos which was evident
by enhanced levels of newly synthesized RNA and a sig-
nificant reduction in asymmetric expression of nascent
RNA. Notably, a positive correlation between the increase
in nascent RNA synthesis and full-term development of
cloned mice was observed. In cloned pig embryos, Whit-
worth et al. [28] reported that Scriptaid treatment signifi-
cantly affected the expression of 7 of the 14 transcripts
evaluated and returned three of them to levels observed in
in vivo-derived embryos. Even though a single defect in
transcription reprogramming may cause a “ripple” effect
resulting in the aberrant expression of entire networks of
downstream target genes [29], the analysis of a small num-
ber of transcripts is of limited value for the systematic
study of the genetic interactions involved in a complex
trait. Post genomic era approaches, including genome
wide analyses and network investigations, are needed.
This is the first study that seeks to assess the effects of
assisted epigenetic modifications on transcriptional profiles
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of bovine SCNT embryos with a complete embryo
RNAseq-derived microarray which includes splice and
3′UTR variants [30]. To investigate the potential meaning
of the alteration of specific genes or categories of genes,
we also attempted to associate specific mechanisms or
events that occur in somatic cells, reconstituted oocytes
and developing embryos with the observed alterations.
Since no study has examined the effects of HDAC inhibi-
tors on transcriptome and associated events, our results
will expand the knowledge in this enigmatic field.
Results
TSA treatment improves in vitro, but not in vivo,
developmental competence of SCNT bovine embryos
The custom in vitro measure of cloning efficiency is the
yield and quality of blastocyst formation [5]. In our re-
sults (Additional file 1: Table S1A), cleavage rate was not
significantly different between the groups. However, TSA
treatment boosted blastocyst development to a rate that
was significantly higher than CTR-NT, but not IVF
(39.8 ± 4.1 vs. 28.7 ± 5.5 vs. 34.3 ± 3.9 %, respectively).
Development to grade 1 & 2 blastocyst was not different
between TSA-NT and IVF (48.0 ± 6.0 vs. 41.7 ± 4.2 %,
respectively) but significantly less in CTR-NT (34.7 ±
6.7 %) compared to TSA-NT. Differential staining of
blastocysts (Additional file 1: Table S1B) revealed a
comparable total cell number between the groups. How-
ever, TSA treatment, but not the embryo production
method, changed the distribution of cells in blastocysts as
the proportion of cells allocated to the ICM and ICM/
TCN proportion, were both significantly higher in TSA-
NT blastocysts compared to CTR-NT embryos.
The ultimate readout of cloning efficiency is the ability
of SCNT embryos to develop into viable offspring [5].
Although numbers are low, the transfer of grade 1 & 2
blastocysts resulted in comparable early (days 35–40)
pregnancy rates between the groups (Additional file 1:
Table S1C). However, total percentages of pregnancy loss
between critical pregnancy days 60–120 were high for
both NT groups with no beneficial effect of TSA treat-
ment when compared to no failure in IVF pregnancies.
In addition, a number of pregnancies from SCNT in
both groups were terminated at days 100–235 due to ex-
cessive accumulation of amniotic fluid (hydrops) and
other complications (CTR-NT: 33.3 %, TSA-NT: 50.0 %).
Elective C-section was performed between days 286 to
290 of pregnancy resulted in the delivery of 6 CTR-NT
and 2 TSA-NT calves. Four CTR-NT claves and one
TSA-NT calve did not survive. The deceased calves suf-
fered from placental abnormalities including placental
hypertrophy and small numbers of larger placentomes.
TSA treatment, not the SCNT process, is the greatest
source of variation at the transcriptome level
Significance analysis of microarray (SAM) of blastocysts
revealed that out of the 37,238 targeted gene transcripts
represented on the microarray slide, a relatively small
number of genes were differentially expressed (DEG) in
CTR-NT (1592 = 4.3 %) and TSA-NT (1907 = 5.1 %) em-
bryos compared to IVF (FDR 1.5, P ≤ 0.05, FC ≥1.5)
(Fig. 1a). Of the DEGs identified, 598 and 999 genes
were upregulated and 994 and 908 genes were downreg-
ulated in CTR-NT and TSA-NT embryos, respectively.
The identity and description of top molecules and each
differentially expressed transcripts in CTR-NT and TSA-
NT blastocysts are listed in Additional file 2: Table S2
and Additional file 3: Table S3, respectively. Compari-
sons between genes commonly upregulated or downreg-
ulated between CTR-NT and TSA-NT embryos revealed
that approximately almost all of the downregulated
Fig. 1 Microarray graphical results. a Overview of differential gene expression in CTR-NT and TSA-NT day 7 blastocysts compared to IVF counterparts.
The total number of differentially regulated genes which comprised the total number of upregulated and downregulated genes is shown by directions
of arrows. The Venn diagram shows the overlap between deregulated genes in both SCNT groups. b Venn diagram illustration of the overlap between
genes predominantly and exclusively expressed in CTR-NT, TSA-NT and IVF -derived blastocysts. c Two-dimensional principal component analysis (PCA)
indicating the source of variation in the overall transcriptional profiles of CTR-NT vs. IVF and TSA-NT vs. IVF in this study with the transcriptional profile
of in vivo blastocysts obtained from the study of Gad et al. (2012) using the same array platform
Hosseini et al. BMC Genomics  (2016) 17:16 Page 3 of 21
genes in either group, half of the upregulated genes in
CTR-NT, and one third of the upregulated genes in the
TSA-NT group were common. Notably, no upregulated
gene in one SCNT group was downregulated in the
other group and vice versa (Fig. 1a).
Owing to the similarities between CTR-NT and TSA-
NT array results, it was interesting to define the probe
sets exclusively expressed in the blastocysts of either
group. Out of the 37,238 targeted gene transcripts on the
microarray slide, 231, 631, and 1053 probe sets had a sig-
nal higher than the summation of background intensity
plus two times the SD of background, indicating the
unique presence of the mRNA for these genes in CTR-
NT, TSA-NT, and IVF embryos, respectively (Fig. 1b and
Additional file 4: Table S4). From this list, HDAC11 and
FZD7 were expressed in CT-NT; WNT9B, TET2, FZD10,
IGF1R, STAT6, and H2AFY2 were expressed in TSA-NT;
and XIST, ELK4, FZD3, NOTCH1, PDE3A, KDM2B, and
FOXO4 were expressed in IVF embryos.
TSA does not correct specific transcriptional errors of
SCNT in bovine
To investigate the possibility of reprogramming error hot-
spots, the chromosomal distribution of deregulated genes
was reviewed to identify gene loci preferentially affected in
both groups. Chromosomal map view of deregulated genes
revealed a high degree of consistency between CTR-NT
and TSA-NT blastocysts (Fig. 2a). The upregulated genes
were evenly distributed while chromosome 7 (Fig. 2b)
contained a higher number of deregulated genes. A bias
in the distribution of downregulated genes was observed
with as many as 15 % of the transcripts in both SCNT
groups from genes located on chromosome X (CTR-NT:
147/994, TSA-NT: 136/906) (Fig. 2c).
In order to decipher the location and proportion of
genes that could be related to this conflict, the whole tran-
scriptome patterns of both groups were viewed for a dir-
ect comparison on the same graph (Fig. 3a). Analysis of
microarrays using 5 % FDR and at least 1.5 fold changes
(FC) revealed that genes with FC ≤ 1.5 and FC ≤ −1.5 had
the greatest and lowest similarities between both groups,
respectively; whereas genes with −1.5 ≥ FC ≤1.5 (non DEG
transcripts) were the source of greatest variation between
the two groups. Figure 3b and c represent the overall top
DEGs similarly upregulated and downregulated in CTR-
NT and TSA-NT blastocysts, respectively.
Even if the TSA-NT blastocysts were transcriptionally
different from the IVF blastocysts, our previous study,
using the same platform, revealed a great divergence be-
tween the transcriptomes of in vitro- and in vivo-derived
bovine blastocysts [31]. This led us to determine whether
the divergence observed between TSA-NT vs. CTR-NT
and IVF could be related to the effect of TSA treatment
Fig. 2 Temporal and spatial map views of DEGs in CTR-NT and TSA-NT blastocysts. a Chromosomal distribution of differentially expressed genes in
CTR-NT (open bars) and TSA-NT (black bars) -derived blastocysts. b & c Breakdown of DEGs on chromosome 7 (b) and X (c) based on their location
maps in Ensembl data base (http://asia.ensembl.org). The red and blue graphs represent the number of protein-coding genes and short non-coding
genes in area, respectively. The black line graphs represent the number of repeat sequences and the red graphs represent GC percentages. The red
and green circles represent upregulated and downregulated genes, respectively, in CTR-NT and TSA-NT-blastocysts. The magnified panels are to better
show the genes located in these chromosomal regions
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on the correction of genes commonly deregulated in
CTR-NT and IVF embryos. Principal component analysis
(PCA) comparison between the transcriptomes of CTR-
NT vs. IVF, TSA-NT vs. IVF in the present study with in
vivo blastocysts (in Gad et al. [31]) clustered the in vivo
blastocysts away from the other groups, indicating a
divergence between TSA-NT and in vivo blastocysts at the
transcriptome level (Fig. 1c). Among the genes that were
considered deregulated in CTR-NT and TSA-NT com-
pared to IVF, 131 and 68 upregulated and 16 and 12
downregulated genes had closer expression levels to in
vivo embryos, respectively (data not shown).
Fig. 3 The convergence and divergence between CTR-NT and TSA-NT transcriptomes. a Direct comparison between total array results of both SCNT
groups. All genes were identified for direct comparison with reference to CTR-NT array. b & c Overlaps between top DEGs that were upregulated (b)
and downregulated (c) in CTR-NT and TSA-NT blastocysts
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WNT and FGF canonical pathways are similarly affected in
CTR-NT and TSA-NT blastocysts
The core pluripotency triad (OCT4, NANOG, and SOX2)
was similarly affected in both NTgroups: OCT4 was upreg-
ulated, NANOG was downregulated, and SOX2 expression
was similarly expressed compared to IVF. Treatment with
TSA did not change the expression of OCT4 and SOX2
and resulted in further downregulation of NANOG (4-fold
compared to the 1.7-fold decrease that was observed in
CTR-NT compared to IVF). A reference diagram showing
the interactions of five canonical pathways with OCT4,
SOX2 and NANOG (http://www.cellsignal.com/) was used
to extrapolate the possible pathways that could lead to
the observed expression patterns of the genes of the
core pluripotency triad (Fig. 4). Examination of genes
involved in different canonical pathways revealed that the
transcripts for the cytoplasmic mediators of the FGF path-
way: PI3K, MEK1/2, were not functionally expressed in
the SCNT groups; whereas a few isotypes of the nuclear
mediators AKT, ERK1/2, were upregulated. WNT ap-
peared not functional at upstream regulators and destruc-
tive complexes of β-CATENIN: PP2A, AXIN, GSK3, APC,
were not in an active state to trigger β-CATENIN cyto-
plasmic ubiquitination, and correspondingly, β-CATENIN
transcripts were apparently free to be shuttled into the
nucleus in an upregulated form. TGF-β and BMP were
in a repressed state as their upstream and downstream
regulators were almost downregulated or not significantly
expressed compared to IVF. Notably, a bias was observed
in the expression of SMADs between the NT groups:
SMAD2 and 3 were both downregulated in CTR-NT
while SMAD4 was downregulated in TSA-NT. The
expression pattern of the NOTCH signaling pathway
was similar between the groups with the exception of
NOTCH3 which was downregulated in CTR-NT but not
in TSA-NT blastocysts.
Fig. 4 Signaling pathways in CTR-NT and TSA-NT blastocysts. Overview of expression pattern of genes involved in ESC pluripotency and differentiation
in the CTR-NT and TSA-NT array results. Each gene can be upregulated, downregulated, or of no-significant expression based on its color in red, green,
and gray, respectively. Each gene represents the expression level in both NT groups, the right half of each gene symbol represents expression level in
TSA-NT and the left half represents the expression level in CTR-NT embryos
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TSA effects on epigenetic alterations do not recapitulate
changes in chromatin remodeling, epigenetic gene
expression, and OCT4 and nascent mRNA expression
The heart of cellular reprogramming is epigenetic modifi-
cations and it has been suggested that epigenetic modifiers
such as TSA have a carryover effect on a wide variety of
epigenetic cellular characteristics [26]. To investigate the
potential meaning of the alteration of the expression of
specific genes or categories of genes, we attempted to de-
termine whether these alterations in gene expression were
associated with specific mechanisms or events that occur
in somatic cells, reconstituted oocytes and developing
embryos.
Epigenetic marks
Flow cytometry analysis revealed that the TSA treatment
significantly increased H3K9 acetylation (280.4 ± 4.1 vs.
128.2 ± 6.3) but had no measurable effect on DNA-
methylation (140.6 ± 1.2 vs. 138.1 ± 3.5) in fibroblasts
compared to untreated cells. Epifluorescent microscopy
analysis of blastocysts (Fig. 5a-h) detected the highest
and lowest levels of DNA-methylation in CTR-NT and
IVF embryos (48.5 ± 7.3 and 10.3 ± 6.5, respectively).
Although TSA treatment significantly decreased DNA-
methylation (36.3 ± 6.9) compared to CTR-NT, this
level of DNA-methylation was still significantly higher
than in IVF embryos. The mean intensity of H3K9
acetylation in IVF embryos was significantly higher
than in both NT groups and that of TSA-NT significantly
higher than CTR-NT (65.3 ± 6.5 vs. 55.2 ± 9.3 vs. 40.1 ±
11.6, respectively).
Immunofluorescence staining of the reconstituted
oocytes showed a marked effect of TSA treatment on
the profile of 5mC disappearance and 5hmC generation
that is best viewed in Fig. 6 (a1-a’5, b, c1-c’5, d). The peak
of 5mC in CTR-NT oocytes was observed immediately
following SCNT and a very faint 5hmC was also observed.
Subsequently, 5mC gradually disappeared concomitantly
with the appearance of 5hmC. The exception was a signifi-
cant drop of 5hmC at 12 h post-reconstitution (hpr),
which corresponds to the time of DNA synthesis [32].
However, TSA-treated fibroblasts contained less than half
of the 5mC and approximately 4-fold more of the 5hmC
signals compared to what was initially observed in the
CTR-NT reconstituted counterparts (30.1 ± 5.4 vs. 72.3 ±
3.1 and 19.3 ± 5.1 vs. 5.1 ± 1.1, respectively). Apart from
this initial difference and despite the gradual pattern of
5mC disappearance in TSA-NT oocytes, the 5mC signals
that were observed at 24 hpr were very similar between
TSA-NT and CTR-NT reconstituted oocytes (14.1 ± 2.4
vs. 11.3 ± 3.6, respectively). The initial higher intensity of
5hmC signals in TSA-NT compared to CTR-NT was also
observed at the subsequent stages of assessment.
Chromatin remodeling
The kinetics of nuclear remodeling was quite comparable
between CTR-NT and TSA-NT reconstituted oocytes
(Fig. 6 e1-5). At 2 hpr, the majority of the nuclei were still
intact with only minor signs of bipolar spindle formation.
At 4 hpr, the overall incidence rates of nuclear remodeling
were not different between the groups. Irrespective of TSA
treatment, the majority of the reconstituted oocytes had
prematurely condensed chromosomes on well-structured
bipolar spindles. At 12 hpr, the majority of the reconstituted
oocytes had a single pronucleus which condensed into two
sets of chromosomes in the newly developing blastomeres
at 24 hpr.
Nascent mRNA expression
Neither embryo production method nor the TSA treatment
affected nascent mRNA production. Moreover, all the em-
bryos had early signs of nascent mRNA production on day
Fig. 5 a-h Immunofluorescence of DNA methylation (a-d) and H3K9 acetylation (e-h) in blastocysts developed in CTR-NT, TSA-NT and IVF experiments,
respectively. Bars with different letters differ significantly at P < 0.05. Scale bar represents 100 μm
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Fig. 6 Epigenetic reprogramming and chromatin remodeling in reconstituted oocytes. a1-a’5 Stepwise pattern of 5mC at different intervals (0, 4,
8, 12, 24 hpr) in CTR-NT (a1-a5) and TSA-NT (a’1-a’5). b Comparison between intensity levels of 5mC at different intervals (0, 4, 8, 12, 24 hpr) in
CTR-NT (blue line) and TSA-NT (red line). c1-c’1 Stepwise pattern of 5hmC at different intervals (0, 4, 8, 12, 24 hpr) in CTR-NT (c1-c5) and TSA-NT
(c’1-c’5). d Comparison between intensity levels of 5hmC at different intervals (0, 4, 8, 12, 24 hpr) in CTR-NT (blue line) and TSA-NT (red line). e1-e5
Stepwise pattern of nuclear remodeling pictured from 0.5 to 24 h post reconstitution. The merged images of microtubule and nuclear immunostaining
have been shown. e1 the very sign of nuclear swelling without spindle formation, e2 nuclear remodeling without spindle formation, e3 premature
chromosome condensation with developing spindles, e4 single pronucleus completely developed with an early SCNT zygote,) first mitotic division of
the newly developed SCNT zygote. Bars with different letters differ significantly at P < 0.05. Scale bar represents 100 μm
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3 when they had at least 16 cells. From the 16-cell stage
onward, clear signs of nascent mRNA production were
observed in the embryos of both NT groups (Additional
file 5: Figure S1a-e’).
Further confirmation of the null effect of TSA on
nascent mRNA expression was obtained by using NT
embryos reconstituted with fibroblasts carrying the
OCT4 promoter-driven enhanced green fluorescent pro-
tein (EGFP) (Fig. 7a-c). Irrespective of TSA treatment,
EGFP signals, indicative of OCT4 gene activation, were
not observed until the embryos reached the morulae stage.
All the blastocysts emitted clear EGFP signals (Fig. 7a-c)
and the mean intensities of EGFP fluorescence were
not significantly different between CTR-NT and TSA-NT
blastocysts (25.5 ± 5.6 vs. 22.9 ± 5.2, respectively).
Epigenetic gene expression
Examination of genes involved in epigenetic regulation
of pluripotency revealed that among genes involved in
de novo DNA-methylation, DNMT3 A & B were upregu-
lated and HELLS was downregulated in both NT groups
compared to IVF embryos. Among genes involved in
safeguarding epigenetic permissiveness of pluripotency,
JARID2 was downregulated in both NT groups, CDYL
was downregulated in TSA-NT and CDYL2 was upregu-
lated in CTR-NT groups (Fig. 8).
Functional classification and pathway analysis
Ontological classification of differentially downregulated
genes using IPA generated several biological processes
including cell death and survival, cell-to-cell signaling
and interaction, cancer, as well as embryo development
as the most significant functions similarly affected in
CTR-NT and TSA-NT blastocysts (Additional file 6:
Table S5 and Additional file 7: Table S6). However, bio-
logical processes emerging from differentially upregulated
genes were different between CTR-NT and TSA-NT
groups. Cellular assembly and organization were the
biological functions most significantly affected in CTR-
NT blastocysts with upregulation of the highest number
of genes. For TSA-NT-derived blastocysts, cell growth
and proliferation, carbohydrate metabolism and mo-
lecular transport were the biological functions most
significantly affected with upregulation of the highest
number of genes.
IPA clustered different top canonical pathways for each
group with ratios ranging from 3 to 22 % (proportion of
DEGs to the total number of genes involved in each path-
way) at P-value < 0.05. Aryl hydrocarbon receptor signaling
and glutathione-mediated detoxification in CTR-NT, and
EIF2 signaling and mitochondrial dysfunction in TSA-NT
were the most dominant canonical pathways revealed.
The IPA was also queried for the identification of the
gene regulatory networks (GRNs) between genes that
were either commonly or predominantly expressed in
both NT groups (Fig. 9). The MYC-associated regulatory
pathway was the dominant pathway that emerged from
the genes upregulated in both groups with upregulation
of genes involved in epigenetic regulation of pluripotency
(DNMT3 A & B, CARM1) and TE lineage (GATA4) [13].
Pluripotency and cell survival pathways were the most
stringent pathways that emerged from the genes upreg-
ulated in both groups. The central molecules in this
pathway were NANOG and CASP8 which act as gate
keepers of pluripotency and apoptosis. Among the genes
upregulated in CTR-NT vs. IVF, the amyloid precursor
protein-associated (APP) pathway emerged with direct re-
lation to TET3, E2F1, ARID3A and FRD1. Several GRN
nodes emerged from genes upregulated in the TSA-NT
group and this culminated in the upregulation of a
number of developmentally important genes including
SNRPN, PRKAB1, ARRB2, GADD45G, and GEMIN4.
In the same way, several GRN nodes including KDM5B,
STAT2, NOTCH1, FOXC2, and HSPB1 were observed
within genes upregulated in CTR-NT. Finally, VIM and
YWHAG, KIT, HDAC8 were central molecules of the
Fig. 7 EGFP expression in SCNT embryos harboring EGFP-OCT4 promoter observed under normal light (a), and 557 nm excitation of UV filter (b).
Comparative EGF-Oct4 expression between CRT-NT and TSA-NT embryos at three different stages of in vitro embryo development (c). Bars with
different letters differ significantly at P < 0.05. Scale bar represents 100 μm
Hosseini et al. BMC Genomics  (2016) 17:16 Page 9 of 21
pathways that emerged from genes downregulated in
TSA-NT blastocysts.
Identification of TSA effects on fibroblast gene expression
To identify the effects of TSA on fibroblast gene ex-
pression, microarray data were queried to select a subset of
non-DEG transcripts that were oppositely expressed be-
tween CTR-NT and TSA-NT blastocysts. The selected
subset of genes included CXXC5, LAMA1, STEAP2,
UBD, SAP30L, MT1A, RAB9A, HIST2H2B, SFN, ARPC1B,
SOR1, ARHGEF6, LIX1L, PPP1R5B, and OXCT1. Using
qRT-PCR, the transcripts that were differentially expressed
between treated and untreated fibroblasts were classified as
altered transcripts as described by Whitworth et al. [28].
The fibroblast altered transcripts that had higher normal-
ized expression towards IVF in CTR-NT rather than TSA-
NT blastocysts were classified as corrected transcripts
(Figs. 10 and 11). The fibroblast altered transcripts that had
Fig. 8 Epigenetic landscape in CTR-NT and TSA-NT blastocysts. Overview of the crosstalk between pluripotency factors and epigenetic modifiers
in the CTR-NT and TSA-NT array results. Genes located in the chain are ESC safeguard genes, and genes located in the ramp are differentiating
factors. JMJD1C and JMJD1A work through inhibiting the H3K9me2&3 which are also differentiation factors. Each gene represents the expression
level in both NT groups, the right half represents expression level in TSA-NT and the left half represents the expression level in CTR-NT embryos
Fig. 9 Gene regulatory networks in CTR-NT and TSA-NT blastocysts. Gene regulatory networks representing genes predominantly or commonly
up/down -regulated in CTR-NT and TSA-NT -derived blastocysts
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Fig. 10 Identification of TSA effects on fibroblast gene expression. Protocol used for identifying effects of TSA on the expression profile of a subset of
genes that were oppositely expressed between CTR-NT and TSA-NT blastocysts. The altered transcripts in the fibroblasts that had higher normalized
expressions toward IVF in CTR-NT rather than TSA-NT blastocysts were classified as corrected transcripts. The influenced transcripts in the fibroblasts
that had higher normalized expressions toward IVF in TSA-NT rather than CTR-NT blastocysts were classified as flawed (over-compensated or
under-compensated) transcripts
Fig. 11 TSA differently affects fibroblast gene expression. Almost transcripts (panels a, b, and c), except for the UBD transcript (panel d), were altered
after TSA treatment of fibroblasts. Alterations in LAMA1, CXXC5, and ARPC1B resulted in subsequent correction of their expression in TSA-NT blastocyst
when compared to IVF. However, alterations in ARHGEF6, SAP30L, MT1A, RAB9A and OXCT1 resulted in subsequent over-compensation of these genes
compared to IVF. On the other hand, alterations in STEAP2, HIST2H2B, SFN, SOR1, LIX1L, and PPP1R5B resulted in their subsequent under-compensation
in TSA-NT blastocysts
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higher normalized expression towards IVF in TSA-NT
rather than CTR-NT blastocysts were classified as flawed
(over-compensated or under-compensated) transcripts
(Fig. 10). In this respect, we observed that all transcripts,
except for UBD, were altered after TSA treatment of fibro-
blasts (Fig. 11). Of these, alterations in LAMA1, CXXC5,
and ARPC1B resulted in subsequent correction of their
expression in TSA-NT blastocysts when compared to
IVF. However, alterations in ARHGEF6, SAP30L, MT1A,
RAB9A and OXCT1 resulted in subsequent over-
compensation of these genes compared to IVF. On the
other hand, alterations in STEAP2, HIST2H2B, SFN,
SOR1, LIX1L, and PPP1R5B resulted in their subsequent
under-compensation in TSA-NT blastocysts (Fig. 11).
Microarray validation with qRT-PCR
To validate the microarray results, fourteen genes were
selected to include genes that were significantly upregulated
(OCT4, CMYC, GATA4), downregulated (XIST, NANOG,
GSTM3, CCNB1)) and non-significantly (VEGF, BCL2,
SOX2, CDX2, HNF4a, BMPR1B, SMAD1) deregulated ac-
cording to the microarray results. The overall profiles of
gene expression obtained by qRT-PCR revealed positive
validation of microarray results as the majority (93 %) of
the selected genes had expression profiles consistent with
those observed with microarray analysis (Additional file 8:
Table S7). The only exception was for the expression of
SMAD1. While similar expression levels of SMAD1 were
observed with microarray for both NT groups, qRT-PCR
showed significant downregulation of SMAD1 in CTR-NT
blastocysts. Overall, these validations allow confident inter-
pretation of the results obtained by array hybridization and
statistical/functional analysis.
Discussion
A key characteristic of oocyte-mediated reprogramming
to pluripotency is that the process is very inefficient with
only a few viable embryos obtained at the end [5]. Etio-
logically, most studies point towards an aberrant gene
expression following errors in the erasure and/or re-
building of epigenetic marks that can affect totipotency
and proper differentiation and development of embryos
(for review see [17]). Therefore, several studies have
attempted to modify the epigenetic status of donor cells
using variants of HDAC inhibitors either before or soon
after SCNT. This study represents a collection of physio-
logical, histological and genomic data of unprecedented
completeness to understand the complex phenotype of
SCNT bovine embryos.
In our study, treatment with TSA was quite beneficial
for the in vitro development of SCNT embryos compared
to control nuclear transfer (CTR-NT) and also IVF em-
bryos. The effect of TSA treatment on in vitro development
of SCNT embryos is controversial in different species (for
review see Monteiro et al. [33]). The initial (epi)genetic
background of donor cells may be involved in the gener-
ation of different in vitro results. For example, while TSA
increased cumulus cell-derived cloned mouse blastocysts
by 5-fold, it had no effect on the developmental compe-
tence of ESC-derived embryos [24]. Similarly, TSA
treatment increased blastocyst development of SCNT
bovine embryos produced from fetal fibroblasts but not
bone marrow cells [21]. Notably, TSA treatment altered
the allocation of cells in blastocysts as proportionally
more cells were allocated to the ICM of treated embryos,
suggesting that an overriding epigenetic modification of
the genome before NT has a carryover effect on cell pro-
liferation and differentiation in preimplantation embryos.
Ikeda et al. [34] demonstrated a significant increase in
ICM number in bovine embryos treated with TSA during
IVF. These data convinced us that TSA treatment may
provide better prognosis for in vivo development by pre-
paring better quality embryos.
However, post-implantation developmental competence
was equally compromised in both groups irrespective of
TSA treatment. The majority of NT pregnancies were lost
by the middle of gestation and only a few fetuses survived
in either group. These results are substantially supported
by the fact that even though hundreds of SCNT embryos
were transferred since 1996s, the overall success rate in
terms of live birth rate has not changed and remains quite
low (1–5 %) [35]. Published in vivo studies on HDACis
are both limited and controversial: while TSA was quite
beneficial in mice [25], it could not improve full-term
development in rabbit [36], pig [20], and cow ([37] and
the present study). The different cell lines used as well
as species/strain-specific differences may be involved in
the generation of different in vivo results. For example,
Kishigami et al. [24] observed a significant beneficial ef-
fect of TSA on the full-term development of B6D2F1,
but not of inbred (C57BL/6, C3H/He, DBA/2, and 129/S)
mouse clones. Moreover, while reconstituted pig embryos
derived from fetal fibroblasts could support full term de-
velopment irrespective of TSA treatment, bone marrow
cells of adult sows could do so only after TSA treatment
[21]. This lends support for the different effects of TSA on
in vitro and in vivo development depending on the nuclear
donor cell type. Due to this important difference between
in vitro and in vivo results of SCNT with TSA treatment,
it became relevant to investigate the fundamental molecu-
lar pathways involved in pre-implantation SCNT embryo
development.
The overall results of transcriptomic analysis indicated
that substantial transcriptome reprogramming occurred
at the blastocyst stage which is in agreement with all
the previous studies in bovine [4, 6–10]. Notably, TSA
treatment could not dramatically change the profile of
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differentially regulated genes compared to CTR-NT.
This lack of effect of TSA could be considered in the
light of three facts: i) the epigenetic reprogramming
mediated by oocyte reprogramming factors is much
more efficient than TSA [16], ii) following epigenetic
alteration by TSA, somatic cell nuclei are still refractory to
the epigenetic reprogramming [38], and iii) SCNT-specific
transcriptional errors are of a non-random nature and
are responsive to neither oocyte- nor TSA-mediated re-
programming [39].
Whether specific loci in the genome are preferentially
affected during SCNT (reprogramming error hotspots)
or the SCNT errors have a stochastic nature is still an
elusive controversial question [39, 40]. Consistent deregula-
tion of a defined list of genes would support the hotspot
scenario whereas a stochastic model of reprogramming
would be suggested when an unpredictable list of genes
would emerge from different SCNT runs [40]. Our micro-
array data revealed consistent and predictable profiles of
gene expression between the two SCNT groups irrespective
of TSA treatment. Accordingly, almost all downregulated
genes and a great portion of upregulated genes in either
NT group were similarly expressed in the other NT group.
Moreover, as much as 15 % of the genes consistently down-
regulated in both NT groups were located in chromosome
X. This predictability of individual gene expression on a
global background of multiple gene expression changes
argues for a predominantly non-random, rather than
stochastic, nature of reprogramming errors in bovine
SCNT embryos which is in agreement with the study of
Inoue et al. [39] on mouse SCNT. Similarly, Maruotti
et al. [41] observed a clear bias in the distribution of
differentially expressed genes between IVF and NT-
derived epiblast stem cells in mice with 30 % of DEGs
being localized on chromosome 11. However, Somers
et al. [40] observed different embryo to embryo expres-
sion profiles in bovine SCNT. Although we have used
several pools of embryos for each contrast, a defined
pattern of differences indicates, at least for our fibro-
blast line, non-random reprogramming errors. While
this manuscript was being prepared for publication, a
study appeared by Matoba et al. [42] that identified
genomic domains resistant to ZGA in mouse SCNT by
using comparative transcriptome analysis. Because these
so-called reprogramming resistant regions (RRRs) were
enriched for H3K9me3 in somatic nuclei, and since
mRNA injection of Kdm4d markedly improved SCNT
blastocyst rate from 26.0 to 86.6 %, they introduced
H3K9me3 as the critical epigenetic barrier in SCNT-
mediated reprogramming in mouse. Importantly, com-
bined treatment with Kdm4d mRNA and TSA improved
cloning efficiency compared to alone treatment with TSA,
but not Kdm4d. They suggested that TSA and Kdm4d
have no synergic effect because their effects are modulated
through a similar pathway. This study of Matoba et al.
[42] in mouse may support our hypothesis on non-ran-
dom nature of oocyte-mediated reprogramming errors in
bovine. Therefore, a clear understanding of RRRs in differ-
ent differentiated/differentiating cells and whether RRRs
are of a common or specific-specific nature in mammals
will provide a promising approach for improving the
efficiency of SCNT and induced pluripotent stem cell
(iPS) technologies.
The great number of X-linked genes consistently
deregulated in either group may highlight the importance
of reprogramming difficulties on this chromosome. Among
the deregulated genes, IGF2R was upregulated and
NAP1L5 and XIST were downregulated in both NT groups
compared to IVF. Although both X chromosomes are ac-
tive in the female zygote, one X chromosome endures a
dosage compensation mechanism of transcriptional silen-
cing that proceeds through a complex sequence of events
between hatching and implantation in bovine embryos [43,
44]. Reconstituted SCNT embryos, however, receive one
active and one inactive X chromosome from the donor cell
and hence compromising the natural pattern of imprinting
reprogramming [44]. Interestingly, while Eggan et al. [45]
reported a normal pattern of X chromosome inactivation
(XCI), Xue et al. [46] reported aberrant expression of nine
of ten X-linked genes and hypomethylation of XIST in or-
gans of deceased cloned calves. Similarly, siRNA-mediated
knockdown of XIST resulted in a drastic (>10-fold) in-
crease in the birth rate of male clones [47]. In a subsequent
study the same group showed that although XIST siRNA
injection largely suppressed over-expression of XIST in fe-
male SCNT embryos, it could not improve survival [48]. It
is worth noting that after TSA treatment of female bovine
embryos, Olivera et al. [44] observed an 8-fold decrease in
the percentage of blastocysts expressing detectable XIST,
whereas the expression of G6PD remained unaltered, sug-
gesting specific susceptibility of XIST to in vitro culture
conditions.
The establishment of ESCs analogous to those derived
from human and mice embryos has remained an elusive
goal in ungulates [49]. A clear knowledge of the transcrip-
tional regulation of pluripotency genes is fundamental to
the understanding of the species-specific characteristics in-
volved and might reveal clues to achieve stable ESCs in un-
gulates. Analysis of the mouse embryo has revealed that
several of the genes that are implicated in the divergence of
the ICM are identifiable within the context of five canonical
pathways, namely TGF-β/activin-nodal, FGFR, WNT, BMP
and Notch (http://www.cellsignal.com/). These gene regula-
tory networks provide the molecular foundation for the
stabilization or destruction of the core pluripotency triad
(OCT4, SOX2, and NANOG). Examination of genes in-
volved in different canonical pathways revealed that a
typical bovine SCNT blastocyst may possess functional
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WNT and to some extent FGF signaling pathways, but
TGF-β and BMP pathways are not functional. Notably,
while TSA had no apparent effect on WNT and FGF
signal transduction pathways, it altered the expression
of SMADs. Conversely, Denicol et al. [50] demonstrated
the expression of sixteen WNT genes and other genes in-
volved in WNT signaling in Day 6 morulae, indicating a
functional WNT signaling system. By applying WNT ago-
nists and antagonists, they provided evidence suggesting
that the WNT signaling pathway is conversely associated
with preimplantation embryonic development in bovine.
Despite similarities in the WNT and FGF pathways, CTR-
NT and TSA-NT -derived blastocysts differed in the
expression patterns of SMADs. While the contributions
of SMADs to pluripotency and the downstream events
that they may regulate are poorly understood, the ob-
served bias in the expression profile of SMADs may be
associated with the differences observed in the level of
downregulation of NANOG in TSA-NT- and CTR-NT-
derived blastocysts (4- and 1.7-fold, respectively). The
homeobox NANOG is among the highly conserved
transcription factors implicated in ESC identity, self-
renewal and maintenance, in cooperation with OCT4
and SOX2. Therefore, the observed reduction in the ex-
pression of NANOG should have important implications
in the development of cloned embryos. In contrast, Iager
et al. [19] reported increased expression of NANOG in
SCNT bovine embryos treated with TSA. The transcrip-
tion factor C-MYC is central to a module of highly con-
nected binding sites that are related to different epigenetic
modifications of the core pluripotency-associated network
[51]. C-MYC is expressed in ESC and cancer cells and it
was also upregulated in both SCNT groups in this study.
However, C-MYC functions seem to be distinct from the
pluripotency triad’s functions and it may be more involved
in the regulation of protein metabolism [51]. Double
inhibition of MAPK2 and GSK3 in bovine blastocysts
increased NANOG and SOX2, but not C-MYC [52].
Taken together, the simultaneous expression of both
stimulatory and inhibitory pathways may put the pluripo-
tency of SCNT blastocysts in a precarious contradictory
state compared to IVF counterparts.
Abnormal placental development has been deemed
responsible for the majority of SCNT problems [53–56]. It
is believed that dysfunctional placentation in clones is the
result of aberrant expression of several key transcription
factors that are involved in proliferation (MASH2, ERG,
CDX2, TBPG), differentiation (CDX2, ERG, LOC618696,
PLET1, POU5F1, HAND1) and function (ERG, ERG, IFN-
tau, TKDP1, PAG-9) of trophoblasts [55, 56]. Importantly,
expression of some of these transcripts is increasingly en-
hanced as the bovine trophoblast elongates [55]. In our re-
sults, TKDP1, LOC618696 and TBPG were downregulated
over 3-fold in SCNT blastocysts of both groups, IFN-tau
was downregulated in both groups, and HAND1 was
downregulated in the TSA-NT group. TKDP1 is respon-
sible for trophoblastic Kunitz domain proteins which are
is assumed to protect the developing conceptus against
potentially damaging proteinases released by maternal
cells [57]. Therefore, one may argue that downregulation
of these genes may be involved in the early pregnancy
losses.
It has been demonstrated that assisted epigenetic
modification improves reprogramming efficiency through
improvement of nuclear organization and induction of
synchrony between the blastomeres for the expression of
nascent mRNA [26, 27]. We therefore attempted to follow
the dynamics of nuclear remodeling and nascent mRNA
expression in association with the epigenetic alterations of
the reconstituted oocytes and blastocysts. The most not-
able finding was that TSA treatment resulted in a very
sharp drop in the level of 5mC (by 50 %) immediately after
nuclear transfer coinciding with a parallel increase in
the level of 5hmC (by 4-fold). Interestingly, the 5mC
signal at 24 hpr was comparable to the level observed
in early reconstituted oocytes. However, the 5hmC signal
remained significantly higher in TSA-NT vs. CTR-NT em-
bryos. Similarly, Antony et al. [58] showed that although
induction of jmjd2b in mice ESC substantially decreased
total levels of H3K9me3 by 63 %, the level of H3K9me3
was returned to normal within minutes following fusion
with an enucleated oocyte. Notably, this transient change
in H3K9me3 resulted in a remarkable increase in in vitro,
but not in vivo, development which is in agreement with
our results. The second finding was that the global levels
of DNA-methylation and H3K9 acetylation in TSA-NT
blastocysts were modified to levels similar to IVF blasto-
cysts and this is in agreement with all the other studies
[16–19, 31]. It remains enigmatic how TSA could affect
blastocyst formation but not post-implantation health.
These dramatic changes in initial (5mC, and 5hmC) and
final (DNA-methylation and H3K9 acetylation) levels of
these crucial epigenetic markers did not recapitulate the
changes in chromatin remodeling and epigenetic genes
expression. Notably, the time-window of nascent OCT4
and nascent mRNA expression was not altered by TSA
treatment. In agreement, using GFP-expressing fibroblasts
fused to oocytes reconstructed either before (metaphase)
or after (telophase) activation, Bordignon et al. [59] could
not detect GFP signals until the 8- to 16-cell stage regard-
less of the cytoplast used, suggesting equivalent functional
remodeling of chromatin activity in embryos recon-
structed with both types of cytoplasts. In contrast, Bui
et al. [26] and VanThuan et al. [27] demonstrated a more
effective formation of DNA replication complexes in
TSA- and Scriptaid-treated mouse embryos which was ev-
idenced by enhanced levels of newly synthesized RNA and
significant reduction in asymmetric expression of nascent
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RNA. Based on our previous study on TSA treatment of
early reconstituted embryos [18], this controversy may not
be related to TSA treatment of nuclei donor cells or early
reconstituted oocytes but instead may be related to species-
specific differences in the timing of zygotic genome activa-
tion (ZGA) (2-cell in mice and 8–16-cell in bovine [1]).
These differences provide an unwanted variability in the
timing of assisted epigenetic modification in relation to the
timing of maximum epigenetic alteration and ZGA.
Conclusions
This is the first comprehensive study on the effects of
assisted epigenetic modifications on the transcriptome of
bovine SCNT blastocysts studied with a microarray chip
which covers the bovine preattachment transcriptome and
hence allows the exploration of gene expression in bovine
blastocysts obtained in different conditions. The results
obtained demonstrated substantial reprogramming of the
donor cell nuclei by the blastocyst stage with no overt ef-
fect of TSA on the number and identity of differentially
regulated genes. Considering the limited number of genes
deregulated in SCNT embryos, one may suggest that a
simple defect in the expression of a few genes may trans-
late into defective expression of a great number of genes
in a ripple effect. This may also suggest a non-random na-
ture of SCNT-specific errors that are not TSA-responsive.
This also suggests that the miracle of cloning lies in the
great capacity of the ooplasm to reprogram almost any
type of differentiated cells; but the problems of cloning are
due to unstable genes that escape/resist reprogramming
and are not responsive to TSA. Therefore, future studies
should focus on these potentially important deregulated
genes involved in extra-embryonic tissue modelling to find
strategies to correct their expression before the embryos
are transferred to recipients.
Methods
Unless otherwise specified, all chemicals and media were
obtained from Sigma-Aldrich (St. Louis, MO, USA)
and Gibco (Life Technologies, Rockville, MD, USA),
respectively. All animal care and surgical procedures were
undertaken in strict accordance with the approval of
the Institutional Review Board and Institutional Ethical
Committee of Royan Institute (No#94321).
Experimental design
The objective of this study was to investigate the effects
of TSA treatment of donor cells on the transcriptional
profile of cloned embryos compared to control SCNT and
IVF embryos (hereafter TSA-NT vs. CTR-NT vs. IVF, re-
spectively) and to identify specific genes or categories of
genes that could account for specific mechanisms or events
that occur in somatic cells, reconstituted oocytes and devel-
oping embryos. To meet these objectives, an established
fetal fibroblast cell line obtained from an approximately 60-
day female fetus, was treated with a previously established
concentration and duration of TSA (1.0 μM for 24 h, [60]).
At the end of each treatment, treated and untreated (con-
trol) cells were used for either SCNT or flow-cytometery
assisted analyses of DNA-methylation and histone acetyl-
ation. Yield and quality of embryo development was re-
corded until day 7 when grade 1 & 2 blastocysts were used
for microarray analysis, embryo transfer to recipients and
differential staining. Further, some of the SCNT and IVF
embryos were collected at four intervals post SCNT/IVF (0,
4, 8, 12, 24 h) for immunostaining assessment of epigenetic
marks and chromatin remodeling using immunostaining
against 5-methylcytosine (5mC), 5-hydroxymethylcytosine
(5hmC) and β-tubulin, respectively. Other embryos were
also collected for the assessment of nascent mRNA expres-
sion using immunostaining against BrUTP. Also, fibroblasts
were stably transfected with a construct of EGFP-OCT4
[16] for the detection of the time-window of the expression
of genes for pluripotency in TSA-NT and CTR-NT em-
bryos. Finally, qRT-PCR was used to determine the effects
of TSA on the expression profile of a subset of genes in
fibroblast cells and resulting embryos.
Embryo production by IVF
For in vitro maturation (IVM), cumulus-oocyte complexes
(COCs) were obtained by aspirating antral follicles (2–
8 mm in diameter) of ovaries obtained from an abattoir.
Groups of ten COCs with homogenous cytoplasm and
more than three layers of compact cumulus cells were
placed in 50-μl drops of maturation medium (MM) under
mineral oil and matured for 24 h at 39 °C under an at-
mosphere of 6 % CO2 in air with maximum humidity.
The MM was comprised of tissue culture medium 199
(TCM199) supplemented with 2.5 mM Na-pyruvate,
100 IU/ml penicillin, 100 μg/ml streptomycin, 1 mg/ml
estradiol-17β, 10 μg/ml FSH, 10 μg/ml LH, 100 ng/ml
EGF, 100 ng/ml FGF, 0.1 mM cysteamine, and 10 % fetal
calf serum (FCS) at 39 °C, 6 % CO2. [61].
For fertilization, commercially available frozen semen
straws were thawed (30 s in air and then 1 min in 37 °C
water) and the semen was centrifuged (70 g for 5 min)
to remove the cryoprotectants. The semen pellet was
layered upon a discontinuous PureSperm® gradient (2 ml
of 45 % over 2 ml of 90 % prepared in hepes TCM199
(HTCM199)) and motile sperm were collected after cen-
trifugation (1200 g, 20 min) at room temperature (RT).
Prepared samples were washed twice in hepes-buffered
Tyrode’s albumin lactate pyruvate medium and 2 × 105
sperm were co-incubated with ten COCs in 200 μl
fertilization medium for 18–20 h at 39 °C, 6 % CO2 and
humidified atmosphere. The presumptive zygotes were
then denuded of their cumulus cells and washed twice
with embryo culture medium. Since the SCNT procedure
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used in this study was a zona-free procedure, in order to
alleviate potential bias in the array comparison of SCNT
and IVF blastocysts, the zona pellucida was also removed
from IVF zygotes before culture for in vitro embryo devel-
opment [16].
For embryo culture, a continuous modified synthetic
oviduct fluid (mSOF) containing 100 ng/ml EGF, 0.5 mM
glucose, and 2 μl/ml ITS (insulin, transferrin and selenium)
was used. To preclude aggregation of zona-free embryos,
50-μl droplets of mSOF were prepared under embryo-
tested mineral oil in 3 cm Grainer® dishes. Next, ten small
wells were made by gently pressing a sterile steel rod with a
round tip (500 μm diameter) to the bottom of the culture
dish and the presumptive zygotes were put in separate
wells. The embryo culture dishes were incubated at 39.0 °C
with 6 % CO2, 5 % O2, 90 % N2 and maximum humidity
for 7 days. The numbers of embryos that cleaved and devel-
oped to the blastocyst stage were recorded at day 3 and 7
post-IVF, respectively [16].
Embryo production by SCNT
For somatic cell culture, a skin biopsy from an approxi-
mately 60-day old female fetus was used as the source of
bovine fetal fibroblasts as described previously [60]. After
thorough washing with phosphate buffer saline (PBS) con-
taining antibiotics and antimycotics, the biopsy was cut into
small pieces (2–3 mm2), and the explants were cultured in
Dulbecco’s modified Eagle’s medium F-12 (DMEM/F-12)
containing 10 % FCS and 1 % penicillin-streptomycin at
37 °C in a humidified atmosphere of 5 % CO2 until conflu-
ence. To confirm the fibroblast phenotype, cells at passage
two were immunostained against anti-vimentin (for fibro-
blasts) and anti-pancytokeratin (for epithelial cells). For
TSA treatment, 4 × 105 fibroblasts at passage three were
added to 3-cm culture dishes containing DMEM/F-12 plus
10 % FCS supplemented with either 1.0 (treatment) or 0.0
(control) μM of TSA and cultured for 24 h before being
trypsinized for SCNT or flowcytometry assessment of
epigenetic marks as described elsewhere [60].
For oocyte reconstitution, denuded oocytes were released
from their zona pellucida by brief incubation (up to 45 s) in
5 mg/ml pronase dissolved in HTCM199 containing 10 %
FCS. Enucleation of the oocytes was performed in PBS
free of Ca2+ and Mg2+ and supplemented with 20 %
FCS, 2.5 mM Na-pyruvate, 1 % bovine serum albumin
(BSA), 1 % polyvinyl alcohol (PVA) and 1.5 mM glucose.
Enucleation was carried out at 100X magnification on a
pre-warmed microscope stage (Olympus, IX71) under
constant UV-light exposure with the help of blunt
perpendicular-break enucleation pipettes (15–20 μm inner
diameter). Fibroblast cells were trypsinized immediately
before NT, and a low density of cells was prepared in a
drop of HTCM199 + 0.5 % FCS containing 10 μg/ml
phytohemagglutinin. Five to ten enucleated oocytes were
added to the droplet, and each oocyte was gently pushed
over a single cell. The oocyte-donor cell couplets were
placed between two electrodes (0.5 mm apart), overlaid
with a hypo-osmotic fusion medium (0.2 M mannitol,
100 μM MgSO4, 50 μM CaCl2, 500 μM hepes, and 0.05 %
BSA), aligned first manually and then by application of
AC current (7 V/cm, 1,000 KHz, for 10 s). Fusion was in-
duced by two successive DC current pulses (1.75 KV/cm,
30 μsec with 100 μsec interval) [16]. Fused couplets were
activated within 30 min of electro fusion by incubation
in 5 μM calcium-ionophore for 5 min, followed by 4 h
exposure to 2 mM 6-dimethylaminopurine dissolved in
TCM199 containing 10 % FCS, 0.2 mg/ml PVA, 3 mg/ml
BSA [62]. Activated embryos were cultured and evaluated
as described for the IVF embryos.
Quality assessment of blastocysts
For quality assessment of embryo development, blasto-
cysts were graded according to the guidelines of the
International Embryo Transfer Society (IETS). Since it
has not been established whether these grading criteria
are at all meaningful for zona-free embryos or SCNT
embryos, we also relied on our own experience [16, 18, 60].
For further assessment of embryo quality, differential stain-
ing to detect total (TCN), inner (ICM) and trophectoderm
(TE) cell numbers was carried out as described previously
[61]. In brief, blastocysts were incubated in 500 μL of 1 %
Triton X-100 and 100 μg/mL propidium iodide for up to
30 s depending on the size of the embryos, and then imme-
diately transferred to 500 μl of a solution of 100 % ethanol
plus 25 μg/mL H33342 and stored at 4 °C overnight. Fixed
and stained embryos were subsequently mounted on glass
microscope slides in one drop of glycerol, gently flattened
with a coverslip, and visualized for cell counting on a
fluorescence microscope (Olympus, BX51) using the
460 nm excitation filter for blue and the 560 nm filter
for red. TE cells were visualized as pink and ICM as
blue. The TCN of each embryo was calculated by adding
the number of ICM and TE.
RNA isolation, amplification, and microarray hybridization
The whole process of microarray analysis was as de-
scribed previously [63]. Total RNA from each replicate
was extracted and purified using the PicoPure RNA Iso-
lation Kit. After DNase digestion (Qiagen), the quality
and concentration of the extracted RNA was determined
with a bioanalyzer (Agilent). All extracted samples were
of good quality with RNA integrity numbers ≥7.0.
For microarray purposes, purified RNA was in vitro
transcribed by T7 RNA amplification using the RiboAmp
HSPlus RNA Amplification Kit (Life Science) and labeled
with Cy3 and Cy5 using the ULS Fluorescent Labeling Kit
(Kreatech). Antisense RNA (825 ng per replicate) was then
hybridized on the Agilent-manufactured EmbryoGENE®
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slides [30] in a two-color dye-swap design. The microarray
chip used, EmbryoGENE®, covers most of the bovine pre-
attachment transcriptome and hence allows the analysis of
gene expression in bovine blastocysts.
After 17 h of hybridization at 65 °C, microarray slides
were washed for 1 min in gene expression wash buffer 1
(RT), 3 min in gene expression wash buffer 2 (42 °C), 10 s
in 100 % acetonitrile (RT) and 30 s in Stabilization and
Drying Solution (Agilent). Slides were scanned with a
Power Scanner (Tecan) and features extraction was done
with Array-pro6.3 (Media Cybernetics). Intensity files were
analyzed with FlexArray 1.6.1 (Michal Blazejczyk, Mathieu
Miron, Robert Nadon (2007), FlexArray: statistical data
analysis software for gene expression microarrays. Genome
Quebec, Montreal, Canada, URL: http://genomequebec.mc-
gill.ca/FlexArray). Specifically, raw data were corrected
by background subtraction, and then normalized within
and between each array (Loess and quantile, respectively).
Statistical comparison between treatments (CTR-NT vs.
IVF and TSA-NT vs. IVF) was done with the Limma algo-
rithm. In pairwise comparisons among transcripts with a
p-value < 0.01, a false discovery rate (FDR) of 20 % and a
fold change >2.0 were considered differentially expressed.
The data discussed in this publication have been deposited
in NCBI’s Gene Expression Omnibus and are accessible
through GEO Series accession number GSE57247 under
URL: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE57247
Validation of microarray results by qRT-PCR
Microarray results were validated by quantitative real-
time PCR (qRT-PCR) as described previously [16]. The list
of selected primers with their characteristics is shown in
Additional file 9: Table S8. In brief, total RNA was extracted
from independent samples (groups of ten blastocysts in
three replicates for each experimental group) using RNeasy
Micro Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s guidelines. The concentration of the ex-
tracted RNA was determined by measuring the absorb-
ance at 260 nm using a spectrophotometer and total
extracted RNA (around 0.5 μg) was used for first strand
cDNA synthesis with the RevertAid® First Strand cDNA
Synthesis Kit (Fermentas, Germany). Each cDNA synthe-
sis reaction contained 1 μl random hexamer primer, 1 μl
RNase inhibitor, 4 μl 5X reaction buffer, 2 μl dNTP, and
1 μl M-MuLV reverse transcriptase and was adjusted to a
total volume of 20 μl using DEPC-treated water. The syn-
thesis of cDNA was performed at 42 °C for 1 h. The qRT-
PCR was carried out using the Rotor Gene 6000 (Corbett®,
Australia). Each reaction mix contained 2 μl cDNA, 10 μl
SYBR Premix Ex Taq II (TaKaRa®, Japan) and 1 μl of 5
pM/ml forward and reverse primers and adjusted to a
total volume of 20 μl using dH2O. The primers were de-
signed using Beacon Designer, checked by NCBI blast,
and finally by gel electrophoresis. The efficiencies of the
designed primer pairs were checked by amplification of a
serial dilution of template cDNA (50, 10, 2, 0.4, and
0.08 ng) and were between 90 % and 100 %. The obtained
CT of each target gene was normalized to the CT of a
housekeeping gene (ACTB) and represented with refer-
ence to IVF as 2-ΔΔCT.
Functional analysis of differential gene expression profiles
The Ingenuity Pathways Analysis (IPA; Ingenuity Systems,
www.ingenuity.com) software was used to group overrep-
resented functions of differentially expressed genes into
clusters. Moreover, IPA was queried to compile canonical
pathways as well as gene regulatory networks (GRNs) that
were differentially expressed between treatments. We used
IPA to build schematic representations of important path-
ways deregulated in SCNT blastocysts [63].
Network generation
A data set containing the gene identifiers and the corre-
sponding expression values was uploaded into the appli-
cation. Each identifier was mapped to its corresponding
object in Ingenuity’s Knowledge Base. A fold-change
cut-off of 1.5 with a P value <0.05 was set to identify
molecules whose expression was significantly differentially
regulated. These molecules, called network-eligible mole-
cules, were overlaid onto a global molecular network devel-
oped from information contained in Ingenuity’s Knowledge
Base. Networks of network-eligible molecules were then
algorithmically generated based on their connectivity.
Molecules are represented as nodes, and the biological
relationship between two nodes is represented as an
edge (line). All edges are supported by at least one refer-
ence from the literature, from a textbook, or from canonical
information stored in the Ingenuity Pathways Knowledge
Base. Human, mouse, and rat orthologs of a gene are stored
as separate objects in the Ingenuity Pathways Knowledge
Base, but are represented as a single node in the network.
Nodes are displayed using various shapes that represent the
functional class of the gene product [63].
Canonical pathway analysis
Canonical pathway analysis identified the pathways from
the IPA library of canonical pathways that were most
significant to the data set. The significance of the associ-
ation between the data set and the canonical pathway
was measured in two ways: 1) a ratio of the number of
molecules from the data set that map to the pathway di-
vided by the total number of molecules that map to the
canonical pathway was displayed; 2) Fisher exact test
was used to calculate a P value to determine the probabil-
ity that the association between the genes in the dataset
and the canonical pathway would occur by chance alone.
Green and red symbols represented genes respectively
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down and upregulated in treated embryos compared to
controls. Gray symbols represented genes with signifi-
cant expression in blastocysts but with no difference
between conditions, whereas white symbols represented
genes not present on microarray or with below-background
intensity [63].
Immunofluorescence
DNA-methylation and histone H3K9 acetylation in
fibroblasts
As described previously [60], quantitative assessment of
DNA-methylation and histone H3K9 acetylation was
conducted by incubating fibroblasts with 1:400 and
1:200 dilutions of mouse anti-5-methylcytosine and
anti-H3K9 monoclonal antibodies, respectively. Fluorescein
isothiocyanate-conjugated goat anti-mouse immunoglobin
was used as the secondary antibody at a 1:50 dilution. A
corresponding control for each experiment was included.
Cells were filtered through a 40-μm nylon mesh in order to
exclude aggregated cells. Ten thousand cells were collected
with the fluorescence activated cell sorting (FACS)-Caliber
and were analyzed using CELL QUEST® 3.1 software
(Becton Dickinson). Three replicates were conducted
for each treatment with appropriate controls to eliminate
the possible effects of auto fluorescence and non-specific
binding by the secondary antibody.
DNA-methylation and histone H3K9 acetylation of
blastocysts
As described previously [16], NT and IVF blastocysts
were washed in PBS containing 1 mg/ml PVA and then
fixed in 4 % paraformaldehyde (PF) in PBS for 30 min.
Permeabilization was carried out in 0.5 % Triton X-100
in PBS for 15 min. For DNA-methylation, embryos were
first pre-treated with 4 N HCl for 60 min at RT, and then
washed with PBS. To preclude non-specific binding of the
primary antibody, embryos were treated with 3 % BSA in
PBS for 60 min at RT. These embryos were then incubated
with the primary antibody: either mouse monoclonal anti-
5-methylcytosine (for DNA-methylation) (Eurogentec®,
BI-MECY-0100) or mouse monoclonal anti-H3K9 (for
histone-acetylation), for 1 h at 37 °C, followed by three
washes in PBS containing PVA. Embryos were then in-
cubated with the secondary antibody (goat anti-mouse
IgG-TRITC conjugate) for 60 min at 37 °C. Subsequently,
embryos were re-fixed overnight in 4 % PF and treated
with 0.1 mg/ml RNase-A for 1 h before being washed in
PBS. The fixed and stained embryos were mounted and
imaged as described for EGFP fluorescence using 557 nm
excitation and 576 nm emission filters. The median pixel
intensity of 10–15 nuclei was detected in each NT and
IVF blastocyst. Briefly, five different regions of each image
that contained 10–15 nuclei were randomly selected and
the average pixel intensity of fluorescence emission in the
nuclei located in these regions was detected using Image J.
software (National Institute of Mental Health, Bethesda,
Maryland, USA). The software was zeroed against
background before use. Appropriate controls were also
included to eliminate the possible effects of auto fluor-
escence of the first and second antibodies.
Chromatin remodeling dynamics
Stepwise assessment of chromatin remodeling was carried
out as described previously [64]. In brief, reconstituted
oocytes at 0.5–12 h post-reconstitution (hpr) were fixed in
4 % PF for 15 min. Microtubules were immunostained
with anti-β-tubulin monoclonal primary antibody (1:100)
and FITC labeled anti-mouse-IgG secondary antibody
(1:100). The chromosomes were counterstained with
H333242 (2 mg/ml) and then samples were washed
and mounted on glass slides in glycerol droplets to be
observed with an epifluorescence microscope (Olympus,
BX51) at 400X magnification. A digital image of each sam-
ple was taken with a highly sensitive camera (Olympus
DP-72) operated on DP2-BSW Software.
5mC and 5hmC dynamics
The disappearance of 5mC and appearance of 5hmC were
assessed as described previously [65]. Briefly, reconstituted
oocytes and IVF embryos at 0, 4, 8, 12, and 24 h post
SCNT/IVF were fixed in 4 % PF for 10 min at RT, washed
several times in PBS-Tween (PBS-T: 0.1 %) and then
permeabilized in 1 % Triton X-100/PBS-T for 1 h. Tissues
were washed again in TBS-T then antigens were blocked
by incubating in 5 % non-fat dry milk/TBS-T for 1 h at
RT. First antibodies were added to fresh blocking solution
at 1:1000 and 1:2000 dilutions for anti-5mC and anti-
5hmC, respectively. Samples were incubated overnight at
4 °C in antibody solution, and then washed in PBS-T sev-
eral times. Goat anti-mouse secondary antibody was di-
luted at 1:2000 in freshly made blocking solution. Samples
were incubated for 45 min followed by four washes of
15 min in PBS-T and incubated in DAPI 1:1000 for nu-
clear staining. Samples were washed and mounted on
glass slides in glycerol droplets to be observed with an epi-
fluorescence microscope (Olympus BX51) as described for
chromatin remodeling.
Nascent mRNA expression
Incorporation of BrUTP into embryos was performed as
described by Bui et al. [26]. In brief, SCNT embryos at
different stages of in vitro development (oocyte, 2-, 4-,
8–16 cells, compact morula and blastocyst) were washed
trice with electrical permeabilization buffer (PB: 0.25 M
D-glucose, 100 μM CaCl2.2H2O, 100 μM MgSO4, and
0.1 % PVP) and then incubated in transcription buffer
(PB + 10 mM BrUTP) for 1 min. Embryos were placed
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between two electrodes (0.5 mm apart) of an electro fu-
sion chamber filled with 20-μL droplets of transcription
buffer and BrUTP internalization was induced by two
successive DC current pulses (250 V/cm, 80 μsec with
1 min interval). Embryos were transferred to mSOF
medium two minutes after permeabilization and cultured
for 1 h. The embryos were then washed twice in PBS-
PVA, fixed for 40 min in PBS-PVA, washed twice in
PBS-PVA and stored overnight at 4 °C in PBS supple-
mented with 3 % BSA and 0.1 % Triton X-100. The em-
bryos were then incubated for 2 h with mouse monoclonal
anti-BrdU (6 μg/mL), washed twice in PBS-BSA before be-
ing incubated for 1 h in 1:200 dilution of Tritc-labeled
goat anti-mouse IgG as second antibody. Embryos were
then washed out trice in PBS-BSA, 10 min each, and ob-
served with high power inverted and then epifluorescence
microscopes as described above. Blastocysts and oocytes
were used as positive and negative controls, respectively.
Nascent EGFP-OCT4 expression
Fibroblasts were transfected with a previously produced
EGFP-POU5F1 plasmid containing a neomycin resistance
gene via lipofection method (LipofectAMINE 2000TM).
The EGFP-POU5F1 vector map and the transfection
protocol are available in a previous article [18]. Stably
transfected colonies, selected after antibiotic screening
and PCR, were expanded before being used for SCNT.
The time window and the extent of EGFP-OCT4 expres-
sion in the developed embryos at the 4- and 8–16-cell,
morulae, and blastocyst stages were assessed by inverted
and then epifluorescent microscopy.
Identification of the effects of TSA on fibroblast gene
expression
To identify the effects of TSA on fibroblast gene expres-
sion, microarray data were queried to select a subset of
non-DEG transcripts in both NT groups that were op-
positely expressed between CTR-NT and TSA-NT blas-
tocysts. The primer list of selected genes is shown in
Additional file 9: Table S8. Then, based on a design de-
scribed by Whitworth et al. [28], qRT-PCR was used to
compare the expression profiles of this subset of genes
in TSA-treated and untreated fibroblasts, and CTR-NT,
TSA-NT, and IVF blastocysts.
Additional files
Additional file 1: Table S1. Pre- and post- implantation development.
Effect of TSA treatment on in vitro and in vivo development of cloned
embryos compared to fertilized counterparts. (DOCX 18 kb)
Additional file 2: Table S2. CTR-NT Differentially regulated genes.
Breakdown of genes differentially up and downregulated with ≥1.5 fold
change in CTR-NT blastocyst compared to in vitro fertilized embryos. Red
and green colors represent up and downregulation, respectively.
(XLS 261 kb)
Additional file 3: Table S3. TSA-NT differentially regulated genes.
Breakdown of genes differentially up and downregulated with ≥1.5 fold
change in TSA-NT compared to in vitro fertilized embryos. Red and green
colors represent up and downregulation, respectively. (XLS 314 kb)
Additional file 4: Table S4. Unique gene expression in CTR-NT and
TSA-NT. A breakdown of genes predominantly or commonly expressed in
CTR-NT- and TSA-NT-derived blastocysts. (XLS 416 kb)
Additional file 5: Figure S1. Nascent RNA expression in CTR-NT and
TSA-NT blastocysts. A-E’) Investigation of nascent RNA expression at different
stages of cloned embryo development. Oocytes and blastocysts are
considered as negative and positive controls based on RNA expression,
respectively. No sign of mRNA expression was observed until the 8 (C&C’) -16
(D&D’) cell stage. Scale bar represents 100 μm. (JPEG 594 kb)
Additional file 6: Table S5. GO terms emerged from CTR-NT blastocyst.
Gene ontology terms emerged from the differentially regulated genes of
CTR-NT blastocysts compared to IVF (FDR 1.5, P≤ 0.05, FC ≥1.5). (XLS 39 kb)
Additional file 7: Table S6. GO terms emerged from TSA-NT blastocyst.
Gene ontology terms emerged from the differentially regulated genes of
TSA-NT blastocysts compared to IVF (FDR 1.5, P≤ 0.05, FC ≥1.5). (XLS 42 kb)
Additional file 8: Table S7. Real Time PCR gene expression analysis.
Validation of microarray results by qRT-PCR quantification of the mRNAs
in blastocysts developed in CTR-NT and TSA-NT groups compared to IVF.
The analysis was done in five replicates of pools of ten blastocysts. ACTB
was considered as housekeeping gene. (DOCX 17 kb)
Additional file 9: Table S8. qRT-PCR primers. Sequences (5′–3′) of
reverse transcription qRT-PCR-specific primers for candidate genes
expressed in bovine embryos. (DOCX 19 kb)
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